How big is the Transdermal Skin Patches Market?

The Transdermal Skin Patches Market size is expected to reach USD 8.92 billion in 2024 and grow at a CAGR of 4.87% to reach USD 11.33 billion by 2029. Read More

What is the current Transdermal Skin Patches Market size?

In 2024, the Transdermal Skin Patches Market size is expected to reach USD 8.92 billion. Read More

Who are the key players in Transdermal Skin Patches Market?

Teva Pharmaceuticals USA Inc., Novartis AG, Teikoku Pharma USA, Inc., Viatris, Inc. and Johnson & Johnson are the major companies operating in the Transdermal Skin Patches Market. Read More

Which is the fastest growing region in Transdermal Skin Patches Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Transdermal Skin Patches Market?

In 2024, the North America accounts for the largest market share in Transdermal Skin Patches Market. Read More

What years does this Transdermal Skin Patches Market cover, and what was the market size in 2023?

In 2023, the Transdermal Skin Patches Market size was estimated at USD 8.51 billion. The report covers the Transdermal Skin Patches Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Transdermal Skin Patches Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Transdermal Skin Patches Market Share

Statistics for the 2023 & 2024 Transdermal Skin Patches market share, created by Mordor Intelligence™ Industry Reports. Transdermal Skin Patches share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Transdermal Skin Patches Industry

The transdermal skin patches market is moderately competitive. The key players are focused on adopting product innovations, product launches and approvals, R&D investment for advancements in transdermal patches, and mergers and acquisitions as their developmental strategies to sustain the competitive market environment. Some major companies in the market are Teva Pharmaceuticals USA Inc., Novartis AG, Teikoku Pharma USA Inc., Mylan Inc., and 3M.